Prohibiting discrimination or retaliation against health care providers by health care entities and credentialing boards for ordering or discussing innovative or novel therapies.
An Act to create 146.50 and 440.208 of the statutes; Relating to: prohibiting discrimination or retaliation against health care providers by health care entities and credentialing boards for ordering or discussing innovative or novel therapies.
This bill prevents health care entities and credentialing boards from discriminating or retaliating against health care providers for ordering innovative therapies or novel therapies [...] The protections provided under the bill do not apply to a health care provider who orders any drug, device, or biological product that is intended to delay or suppress pubertal development in a minor for the purpose of assisting the minor with a gender transition.
2023-2024 Regular Session
|Assembly Amendment 1 offered by Representatives Sortwell and Murphy
|Representative Moses added as a coauthor
|Public hearing held
|Representative Wichgers added as a coauthor
|Read first time and referred to Committee on Health, Aging and Long-Term Care